DexCom (DXCM) Tops Q4 EPS by 41c, Revenues Beat; Offers FY20 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Dexcom Reports Fourth Quarter and Fiscal Year 2019 Financial Results
February 13, 2020 4:01 PM ESTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2019.
Fourth Quarter 2019 Highlights:
Revenue grew 37% versus the same quarter of the prior year to $462.8 million U.S. revenue growth of 34% and international revenue growth of 52% GAAP operating income of $101.5 million or 21.9% of revenue. Non-GAAP operating income* of $103.6 million or 22.4% of revenue Commenced launch of G6 into MedicareFull Year 2019 Highlights:
Full year... More


